Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8458056 | Pathology - Research and Practice | 2018 | 6 Pages |
Abstract
miR-486-5p acts as an oncogene in the progression of NSCLC by influencing PTEN-PI3 K/AKT signaling. miR-486-5p may provide potential therapeutic targets for NSCLC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Zhao-jia Gao, Wei-dong Yuan, Jun-qiang Yuan, Kai Yuan, Yong Wang,